Publication | Closed Access
Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct
47
Citations
34
References
1998
Year
Ki-67 AntigenImmunologyPathologyAgnor ProteinsTumor BiologyOncologyHepatobiliary TumorCancer Cell BiologyMolecular DiagnosticsMolecular OncologyCancer ResearchEhbd CarcinomaLiver PhysiologyHistopathologyBiliary CancersExtrahepatic Bile DuctCell BiologyMalignant DiseaseCumulative Survival RateHepatologyBiliary TractBiliary CancerLiver CancerMedicine
BACKGROUND The authors retrospectively examined the predictive value of p53, MIB-1, and the argyrophilic nucleolar organizer regions (AgNOR) and examined the relationships among them in carcinoma of the extrahepatic bile duct (EHBD). METHODS Formalin fixed, paraffin embedded specimens from 54 patients with EHBD carcinoma were immunostained with MIB-1 against the Ki-67 nuclear antigen and p53 by the avidin-biotin peroxidase complex method, using the antigen retrieval technique of heating tissue sections in a microwave oven. The AgNOR proteins were localized at the optical level, as shown by a one-step silver staining technique. RESULTS MIB-1 and AgNOR were closely associated with lymph node metastasis (P < 0.01). The cumulative survival rate for patients with a low MIB-1 labeling index (LI) (<29%) was significantly better than that for patients with a high MIB-1 LI (≥29%) in cases of EHBD carcinoma (P < 0.05), but MIB-1 was not an independent prognostic factor in multivariate analysis. The results indicated that AgNOR and p53 overexpression had no prognostic value. The authors detected p53 in 24 of the 54 EHBD carcinomas (44.4%). There was a significant correlation between MIB-1 and AgNOR (P < 0.01). The authors found that neither MIB-1 nor AgNOR correlated with p53 overexpression. CONCLUSIONS MIB-1 and AgNOR proved to be useful predictors of lymph node metastasis. The results of this study indicated that MIB-1 and AgNOR might be markers of the progression of EHBD carcinoma. Cancer 1998;82:86-95. © 1998 American Cancer Society.
| Year | Citations | |
|---|---|---|
Page 1
Page 1